Therefore, we aimed to investigate the comprehensive immune-modulatory effects of the combination regimen in our established humanized mice models of HNSCC and lung squamous cell carcinoma (LUSC) harboring EGFR and/or MET expression. Here, EGFR is linked to head and neck squamous cell carcinoma.